| Exchange Traded Funds: Listed on EuroNext | |||||||
| Return to Funds Index | |||||||
| Please see footnotes | Index Country Funds | Current Recommendations | |||||
| Stock | Fund | Investment | Best | Liquid | Correlation | Volatility | Fund |
| Code | Name | Mandate | Proxy | Rating | with World | (Std. Dev.) | Sponsor |
| EEE | Easy EPRA Euro Property | Euro-Zone Real Estate | # | . | 51% | 4.7% | AXA |
| EEP | Easy EPRA EuroPE | Europe Real Estate | . | . | 56% | 5.0% | AXA |
| SYB | Easy Euro Bank | Euro-Zone Finance | # | . | 72% | 6.0% | AXA |
| SYE | Easy Euro Energy | Euro-Zone Resources | # | . | 66% | 4.9% | AXA |
| SHY | Easy Euro Health | Euro-Zone Health Care | # | . | 48% | 5.7% | AXA |
| SYQ | Easy Euro Technology | Euro-Zone Technology | # | . | 66% | 8.8% | AXA |
| CUE | Easy GLOBAL Energy | World Resources | . | *** | 57% | 5.5% | AXA |
| DJMC | iShares DJ Midcap | Europe Small | . | * | 76% | 4.7% | iShares |
| DJSC | iShares DJ SmallCap | Europe Small | # | . | 76% | 4.7% | iShares |
| IDY | iShares Euro STOXX Div | Euro-Zone Value | . | ** | 76% | 5.2% | iShares |
| ISG | iShares Euro STOXX Growth | Euro-Zone Growth | . | * | 76% | 5.5% | iShares |
| IDM | iShares Euro STOXX Midcap | Euro-Zone SmallCap | . | ** | 70% | 5.0% | iShares |
| IDS | iShares Euro STOXX SmallCap | Euro-Zone SmallCap | . | . | 70% | 5.0% | iShares |
| ISV | iShares Euro STOXX Value | Euro-Zone Value | . | . | 76% | 5.2% | iShares |
| IPP | iShares FTSE/EPRA Property | Europe Real Estate | # | * | 56% | 5.0% | iShares |
| BNK | Lyxor BANKS | Europe Finance | . | ** | 76% | 5.6% | Lyxor |
| HLT | Lyxor Health Care | Europe Health Care | . | *** | 59% | 5.2% | Lyxor |
| GWT | Lyxor MSCI Growth | Euro-Zone Growth | # | . | 76% | 5.5% | Societe General |
| MMS | Lyxor MSCI SmallCap | Euro-Zone SmallCap | # | * | 70% | 5.0% | Societe General |
| UST | Lyxor MSCI US Technology | US Technology | # | * | 65% | 8.0% | Societe General |
| VAL | Lyxor MSCI Value | Euro-Zone Value | # | . | 76% | 5.2% | Societe General |
| TNO | Lyxor Technology | Europe Technology | . | * | 70% | 8.7% | Lyxor |
| SMC | StreetTracks Euro SmallCap | Europe Small | . | . | 70% | 5.0% | State Street |
| STN | StreetTracks MSCI Energy | Europe Resources | . | * | 61% | 6.1% | State Street |
| STZ | StreetTracks MSCI Finance | Europe Finance | # | * | 76% | 5.6% | State Street |
| STW | StreetTracks MSCI Health | Europe Health Care | . | * | 59% | 5.2% | State Street |
| STK | StreetTracks MSCI Technology | Europe Technology | # | * | 70% | 8.7% | State Street |
| Back to Top | Managed Country Funds | Current Recommendations | |||||
| Stock | Fund | Investment | Best | Liquid | Correlation | Volatility | Fund |
| Code | Name | Mandate | Proxy | Rating | with World | (Std. Dev.) | Sponsor |
| 970859 | Rolinco | World Growth | # | *** | 96% | 5.2% | Robeco |
| Users of this site must satisfy themselves that the laws of their own country allow them to access the information. This analysis of a general and impersonal nature, in that the advice provided is not adapted to any specific portfolio or any client's specific needs. Private investors should take professional advice as to the suitability of any recommendation. These are updated regularly on the basis of the investment mandate shown, using month end prices, expressed in US$ as a common currency for international investors as well as relative to an index of world stockmarkets. | |||||||
| Back to Top | |||||||
| Copyright © 2006 Professional Investment Tools Ltd., authorised by the Financial Services Authority to carry out investment business in the United Kingdom. Please read Financial Health Warning and Licence Agreement. UK laws apply exclusively. Principal sources: Consensus Economics, Corel Corp., CFTC, FIBV, Global Financial Data, PIT, national governments and stock exchanges. Information and opinions are based on sources believed to be reliable and accurate. However PIT does not guarantee this to be the case, and does not accept liability for any loss arising. These tables are for information only and do not constitute a solicitation to deal in any securities. Opinions are liable to change. Past performance is no guarantee of future success. | |||||||